5 Most Promising Healthcare Stocks According to Analysts

4. Royalty Pharma plc (NASDAQ:RPRX)

Number of Hedge Fund Holders: 36

One-Year Average Price Estimate: $52.98

New York-based Royalty Pharma plc (NASDAQ:RPRX) is operating in the biopharmaceutical industry. Royalty Pharma plc (NASDAQ:RPRX) ranks 4th in our list of the most promising healthcare stocks according to analysts.

In January, Royalty Pharma plc (NASDAQ:RPRX) declared a quarterly dividend of $0.20 per share, which was a 5.3% increase from the prior dividend. Forward dividend yield at the time came in at 2.1%. The dividend was payable on March 15 to shareholders of record as of February 16.

Insider Monkey’s database of 943 hedge funds shows that 36 hedge funds had stakes in Royalty Pharma plc (NASDAQ:RPRX) at the end of the fourth quarter of 2022. The total worth of these stakes was $1.1 billion. The biggest hedge fund stakeholder of Royalty Pharma plc (NASDAQ:RPRX) was Andreas Halvorsen’s Viking Global which had a stake of $396 million.